MapLight Therapeutics, Inc.
MPLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001770069
In the last 90 days, MapLight Therapeutics, Inc. insiders filed 3 open-market purchases and 8 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $941.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding MapLight Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 81 | 2 | 105 | +26 |
| Shares | 24.7M | 54.8K | 26.3M | +1.61M (+6.5%) |
| Value | $502.2M | $1.11M | $941.0M | +$439.9M (+87.8%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held MapLight Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (10)
Institutions that held MapLight Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Vestal Point Capital, LP | 420,000 | $8.54M |
| Ra Capital Management, L.P. | 248,294 | $5.05M |
| Board of Trustees of The Leland Stanford Junior University | 199,231 | $4.05M |
| Polygon Management Ltd. | 112,115 | $2.28M |
| Tudor Investment Corp Et Al | 36,740 | $746.9K |
| Walleye Capital LLC | 11,572 | $235.3K |
| STRS Ohio | 3,000 | $61.0K |
| Root Financial Partners, LLC | 28 | $569 |
| MAI Capital Management | 12 | $244 |
| True Wealth Design, LLC | 3 | $61 |
Not filed for Q2 2026 yet (2)
Institutions that held MapLight Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 54,752 | $1.11M |
| CWM, LLC | 57 | $1.16K |